Cutaneous Warts
11
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts
Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.
Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study
A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts
Infrared Bioeffect System for the Treatment of Cutaneous Warts
CyPep-1 in Cutaneous Warts
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients